About us

WMG Vertical Logo - 494X144px

WellTree Molecular Group assists in the direct sales, distribution, and international business development for revolutionary point of care testing solutions.

Our Story

WellTree Molecular Group is founded by health care operation professionals. Our commitment to excellence and innovation is the guiding philosophy of the team. Our operational expertise has served small and large hospital groups, retail pharmacy, and point-of-care businesses across all patient populations and throughout the U.S.

As the COVID-19 pandemic forced the world into turmoil, the WellTree team adopted the challenge to address the bottleneck of tools and education needed in the war chest to fight against infectious disease. WellTree continually evaluates solutions and products needed to actively fight the pandemic and reopen the country.


Sales Team

Corporate Team

Renée Marchand

Renée Marchand

Pharm.D. & COO
Pharm.D. & COO As COO Renee solves the complex problems that lead the WellTree team through the uncertainty caused by the pandemic. To maximize revenue during the pandemic, Renee works closely with emerging medical device manufacturers to find a space in the marketplace for the value they bring to doctors, patients, and communities. Renee has 10 plus years of experience in the behavioral health care field as a pharmacist. She started her career as a Director of Pharmacy at a 100 bed inpatient facility that serviced pediatrics, adolescents, adults, and active duty military. In the years following, Renee emerged as an integral member of many teams, developing protocols for compliance, service, and audits, exceeding national standards.  Renee’s forward solutions focus and can-do mentality provide guidance to clients seeking to hand over pharmacy responsibility.
Christen Wall

Christen Wall

Chief Revenue Officer (CRO)
Chief Revenue Officer (CRO) Christen joined the WellTree executive team as Chief Revenue Officer only a few months after the coronavirus pandemic hit the United States. As CRO she is charged with building an international sales team and distributor partnerships from the ground up to expand testing capacity at point-of-care. Christen’s unique career experience in sales and entrepreneurship is grounded in core US industries: finance, energy, and transportation. She brings over ten years of experience in business development working in both corporate America and fast growth start-up companies championing sales in emerging industries and greenfield sales. Through uncertain times, Christen delivers impressive growth and drives towards sustainable revenue in order to make WellTree a part of larger partnerships within the established global distribution network of health care solutions. Christen has a Master’s Degree in Environmental Science of Policy and Public Administration from the University of Southern Illinois and a Bachelor’s of Science from Truman State University in Anthropology and Sociology. She has a lifelong passion for improving the global health and prosperity of all communities across the globe.
Szilard Voros

Szilard Voros

External Scientific Advisor
External Scientific Advisor Dr. Szilard Voros, MD, FACC, FSCCT, FAHA is a cardiologist, geneticist and entrepreneur. He is Founder and CEO of Global Genomics Group (“G3”), a precision-medicine-based biotechnology company, developing and commercializing diagnostic biomarkers and novel drug targets for common diseases. G3’s platform is based on the largest-ever program using DNA and RNA sequencing, proteomics, metabolomics, lipidomics and other platforms. G3 has developed a diagnostic blood test for cardiovascular disease and has identified several novel drug targets. Before G3, Voros was Chief Scientific Officer, Chief of Cardiovascular Prevention and Medical Director of Cardiovascular Imaging at Piedmont Heart Institute. He has published extensively in major scientific journals including Nature Reviews, New England Journal of Medicine, Annals of Internal Medicine, Journal of the American College of Cardiology and Circulation: Cardiovascular Genetics, etc.
Andre Claassen

Andre Claassen

Emerging Markets Business Development Director
Andre Claassen obtained his Bachelor’s degree in Commerce from the University of Stellenbosh. He was active in the student councils and Primaruis (Manager) of one of the university residences. Following his studies and along with other partners, Andre acquired a hospitality lodge in South Africa and developed adventure travel in that area. With this business and marketing experience and many years of international travel, Andre then switched focus to currency trading and the business of foreign exchange. In addition to being the representative agent for WellTree’s affairs in Sub-Saharan Africa, he now owns and runs Offshore FX, a 2012 company, that specializes in financial arrangements for importers, exporters and other international money transfers.

Apply for a Job!

We are always looking for quality talent to be a part of the WellTree team. Go to our Careers page for information on current available positions.